The landscape for the pharmaceutical industry is radically changing. A focus on value and budget control, set against the implications of a changing and ageing patient population with an increase in chronic conditions and huge R&D costs has led industry to an increased consideration for lifecycle management to sustain revenues and improve margins.
Regulink can help the pharmaceutical industry to successfully maximise its assets, by traditional LCM strategies, e.g. new formulations or patent extensions, to line extensions of products, acquisitions, generic opportunities, and also licence maintenance and outsourcing activities.